attention deficit hyperactivity disorder(Stage not disclosed)
Status note Granules filed a Paragraph IV ANDA against Adzenys XR-ODT; litigation filed December 2025.
Per-asset detail extracted from the 10-Q filed 2026-05-13. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
No specialist-fund holders in 13F data for this company.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 714 stocks.